-
Mashup Score: 0Beqvez Approved as One-Time Gene Therapy for Hemophilia B - 15 hour(s) ago
Beqvez is a one-time AAV-based gene therapy designed to introduce in the transduced cells a functional copy of the FIX gene encoding a high-activity FIX variant.
Source: www.empr.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
MamaLift Plus is intended as an adjunct to clinician-managed outpatient care to provide neurobehavioral interventions to patients 22 years of age and older with mild to moderate PPD.
Source: www.empr.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0
Nogapendekin alfa inbackicept-pmin is an interleukin-15 receptor agonist.
Source: www.empr.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0
The approval was based on data from the phase 3 VISIBLE 2 trial.
Source: www.empr.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
The double-blind, phase 3 study included 2 groups of patients, those who were not on positive airway pressure therapy and those who were.
Source: www.empr.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
PowerHeal is indicated for superficial wounds such as minor cuts, scrapes, irritations, abrasions, and blisters and is available in a variety of sizes.
Source: www.empr.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Meningococcal ABCWY Vaccine Candidate Under FDA Review - 7 day(s) ago
A regulatory decision is expected on February 14, 2025.
Source: www.empr.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
The approval was based on data from the phase 3 VISIBLE 2 trial.
Source: www.empr.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Tirzepatide Products Continue to Be in Short Supply - 8 day(s) ago
The shortage is expected to continue at least through the second quarter of 2024.
Source: www.empr.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Sudan Ebola Virus Vaccine Candidate Gets Orphan Drug Status - 9 day(s) ago
SuVax is a subunit protein vaccine of recombinantly expressed Sudan ebolavirus glycoprotein.
Source: www.empr.comCategories: General Medicine News, General HCPsTweet
One-time AAV-based gene therapy approved to treat adults with moderate to severe hemophilia B. https://t.co/XQze7P1PUV https://t.co/Vn27VuNlWG